EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC-ND 4.0

Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD

Stela Vujosevic, Emma Zanzottera, Luigi Brotto, Gabriele Piccoli, Camilla Alovisi, Vanda Bucceri, Chiara Rui, Enea Poletti, Marco Brambilla, Michele Coppola, Paolo Nucci, Usha Chakravarthy

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.5.31 ↗

At a glance

Beobachtungsstudie in Investigative Ophthalmology & Visual Science, 2026. Written by Stela Vujosevic and 11 co-authors. Institution: Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy. Major MEDLINE topics: Fluorescein Angiography, Geographic Atrophy, Retinal Pigment Epithelium, Retina. 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

To evaluate the association between spectrally resolved fundus autofluorescence (Sr-FAF) signals and four macular lesion types identified on spectral-domain optical coherence tomography (SD-OCT): (1) drusen, (2) incomplete retinal pigment epithelial and outer retinal atrophy (iRORA) and complete retinal pigment epithelium and outer retinal atrophy (cRORA), (3) retinal pigment epithelium (RPE) and outer retinal atrophy, and (4) nascent geographic atrophy (nGA) in eyes with intermediate and atrophic age-related macular degeneration (AMD).

Methods

This cross-sectional observational study analyzed 775 SD-OCT B-scans from 62 eyes (62 patients) with AMD. Lesions were classified according to established OCT criteria (290 drusen, 49 iRORA, 390 cRORA, 46 nGA). All eyes underwent SD-OCT imaging (97 B-scans) and Sr-FAF using a 450-nm wavelength. Quantitative Sr-FAF metrics (average red emission fluorescence component [REFC] and average green emission fluorescence component [GEFC]) were determined using custom software, and lesion groups were compared via one-way analysis of variance with Scheffé post hoc testing.

Results

Significant differences among lesion types were observed for REFC (F = 59.3, P < 0.001) and GEFC (F = 13.5, P < 0.001). Drusen exhibited higher REFC intensities than iRORA, cRORA, and nGA (all P < 0.001), and higher GEFC intensities than cRORA (P < 0.001) and nGA (P = 0.002). Wavelength (nm) progressively decreased from drusen to iRORA, nGA, and cRORA. Lesion size (in pixels) differed significantly (iRORA < nGA < drusen < cRORA; P < 0.001) and was the strongest predictor (β = -0.31, P < 0.001) in the regression analysis.

Conclusions

Sr-FAF reveals distinct metabolic signatures across AMD lesion types. Higher fluorophore signals in drusen suggest preserved photoreceptor-RPE activity, whereas reduced signals in cRORA and nGA reflect advanced atrophy. Combined SD-OCT and Sr-FAF may enhance the detection of early atrophic changes and improve AMD risk stratification.

Subjects

MeSH terms (MEDLINE)

Fluorescein AngiographyGeographic AtrophyRetinal Pigment EpitheliumRetinaHumansTomography, Optical CoherenceCross-Sectional StudiesFemaleMaleBiomarkersAgedFundus OculiRetinal DrusenAged, 80 and overOptical ImagingMiddle Aged

Substances

Biomarkers

Authors and institutions

  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
  • Eye Clinic, IRCCS MultiMedica, Milan, Italy.
  • Eye Hospital, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Eye Hospital, Oftalmico di Torino, Turin, Italy.
  • CenterVue S.p.A, Padua, Italy.
  • Department of Medical Physics, Azienda Ospedaliero Universitaria Maggiore della Carita, Novara, Piemonte, Italy.

Cite

APA

Vujosevic, S., Zanzottera, E., Brotto, L., Piccoli, G., Alovisi, C., Bucceri, V., Rui, C., Poletti, E., Brambilla, M., Coppola, M., Nucci, P., & Chakravarthy, U. (2026). Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.31

Vancouver

Vujosevic S, Zanzottera E, Brotto L, Piccoli G, Alovisi C, Bucceri V, et al. Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.31

BibTeX
@article{Vujosevic2026,
  author = {Vujosevic, Stela and Zanzottera, Emma and Brotto, Luigi and Piccoli, Gabriele and Alovisi, Camilla and Bucceri, Vanda and Rui, Chiara and Poletti, Enea and Brambilla, Marco and Coppola, Michele and Nucci, Paolo and Chakravarthy, Usha},
  title = {Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.5.31}
}
Start for free →